While the accumulating data suggest that activation of the PI3K/Akt signaling pathway is involved in cell proliferation and growth during endometrial cancer development3, 10, our complementary data support the concept that this signaling pathway can also exert important effects on specific Glut isoform expression and glycolytic metabolism during the onset of uterine insulin resistance. This evidence concerns the gene SLC2A1 and endometrial cancer.